IN2014DN10291A - - Google Patents

Info

Publication number
IN2014DN10291A
IN2014DN10291A IN10291DEN2014A IN2014DN10291A IN 2014DN10291 A IN2014DN10291 A IN 2014DN10291A IN 10291DEN2014 A IN10291DEN2014 A IN 10291DEN2014A IN 2014DN10291 A IN2014DN10291 A IN 2014DN10291A
Authority
IN
India
Prior art keywords
oral
conditions
formulations
prevention
treatment
Prior art date
Application number
Inventor
Rajiv Bhushan
Jerry B Gin
Amit Goswamy
Original Assignee
Rajiv Bhushan
Jerry B Gin
Amit Goswamy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rajiv Bhushan, Jerry B Gin, Amit Goswamy filed Critical Rajiv Bhushan
Publication of IN2014DN10291A publication Critical patent/IN2014DN10291A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Abstract

Oral formulations provided for prevention and treatment of adverse oral conditions such as gingivitis periodontal disease removal of calculus to improve dental hygiene and control of dental plaque and biofilm. Use of the formulations for prevention and treatment of other adverse oral conditions including inflammation and oxidative and/or free radical damage within the oral cavity are provided. Treatable conditions may relate to other conditions or diseases including diabetes AIDS and cancer. Oral formulations containing a biocompatible chelating agent and a permeation enhancer such as methylsulfonylmethane (MSM) are disclosed. Components of the formulations are multifunctional and Generally Regarded As Safe.
IN10291DEN2014 2012-05-03 2013-05-03 IN2014DN10291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261642441P 2012-05-03 2012-05-03
PCT/US2013/039573 WO2013166459A1 (en) 2012-05-03 2013-05-03 Treating inflammatory conditions and improving oral hygiene using metal modulators with methylsulfonylmethane as transport enhancer

Publications (1)

Publication Number Publication Date
IN2014DN10291A true IN2014DN10291A (en) 2015-08-07

Family

ID=49514928

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10291DEN2014 IN2014DN10291A (en) 2012-05-03 2013-05-03

Country Status (11)

Country Link
US (1) US20150132347A1 (en)
EP (1) EP2844344B1 (en)
JP (3) JP6315615B2 (en)
AU (3) AU2013256039A1 (en)
DK (1) DK2844344T3 (en)
ES (1) ES2859682T3 (en)
IL (1) IL235480A0 (en)
IN (1) IN2014DN10291A (en)
PT (1) PT2844344T (en)
RU (1) RU2014148805A (en)
WO (1) WO2013166459A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2694758C2 (en) 2012-12-20 2019-07-16 Раджив Бхушан Antimicrobial compositions
AU2013363982A1 (en) * 2012-12-20 2015-08-06 Rajiv Bhushan Anti-plaque oral compositions
RU2601905C1 (en) * 2015-06-26 2016-11-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Северо-Восточный федеральный университет имени М.К.Аммосова" Method of treating gingivitis
DE102016101280A1 (en) 2016-01-26 2017-07-27 Frank Bröseler Pharmaceutical composition
WO2017195135A1 (en) * 2016-05-11 2017-11-16 Nestec Sa Compositions and methods for reducing or preventing dental calculus accumulation in companion animals
WO2018175522A1 (en) * 2017-03-21 2018-09-27 Gross Andrew J Compositions for treating periodontal diseases
WO2019053260A2 (en) * 2017-09-15 2019-03-21 Nobel Biocare Services Ag Compositions and films for application to dental substrates
CN110194996A (en) * 2019-07-03 2019-09-03 韶关学院 A kind of food borne bacteria biofilm scavenger and its application

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75734C (en) * 1984-12-18 1988-08-08 Lilius Kaj Rainer Munsköljningslösning.
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
JPH06321743A (en) * 1993-05-19 1994-11-22 Sankyo Co Ltd Oral cavity cleaning agent
CA2184316A1 (en) * 1995-09-12 1997-03-13 Wei-Chi Liao Buccal delivery system for therapeutic agents
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
EP1124582B1 (en) 1998-10-27 2003-12-10 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US20060034782A1 (en) * 2001-12-04 2006-02-16 Brown Dale G Biofilm therapy interproximal devices
US6645472B1 (en) * 2002-09-13 2003-11-11 Michael R. Anderson Oral hygiene powder composition and method
JP5583310B2 (en) * 2002-12-20 2014-09-03 チャクシュ・リサーチ・インコーポレーテッド Ophthalmic formulation for prevention and treatment of ocular symptoms
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
ITMI20030195A1 (en) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc TOPICAL FORMULATIONS CONTAINING NATURAL ACTIVE INGREDIENTS SUITABLE FOR THE PREVENTION AND TREATMENT OF MAMMOSE INFLAMMATORY PROCESSES
US20060083727A1 (en) * 2004-07-15 2006-04-20 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation
JP2006182705A (en) * 2004-12-28 2006-07-13 Lion Corp Article to be put on tooth and method for supplying oral cavity care substance
US20060198795A1 (en) * 2005-11-07 2006-09-07 Giniger Martin S Multi-component oral care compositions
CA2615360A1 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Formulation and method for administration of ophthalmologically active agents
US20080038219A1 (en) * 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
BRPI0807943A2 (en) * 2007-02-15 2014-10-21 Derma Young Ltd PHARMACEUTICAL OR NUTRATIC COMPOSITION AND METHODS FOR IMPROVING ADMINISTRATION OF A PHARMACEUTICAL INGREDIENT FOR ORAL MUCOSA AND FOR APPETITE SUPPRESSION
US7850453B2 (en) * 2007-08-08 2010-12-14 Coll Partners Ltd. Reshapable device for fixation at a dental site
AU2009223063A1 (en) * 2008-03-11 2009-09-17 Livionex Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
JP5467800B2 (en) * 2009-05-14 2014-04-09 ロート製薬株式会社 Saliva secretion promoter and composition for promoting saliva secretion
US8434489B2 (en) * 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods

Also Published As

Publication number Publication date
AU2020204162A1 (en) 2020-07-09
JP2015515991A (en) 2015-06-04
JP6315615B2 (en) 2018-04-25
IL235480A0 (en) 2014-12-31
JP2019206572A (en) 2019-12-05
RU2014148805A (en) 2016-06-20
ES2859682T3 (en) 2021-10-04
US20150132347A1 (en) 2015-05-14
PT2844344T (en) 2021-04-06
EP2844344B1 (en) 2021-01-13
AU2013256039A1 (en) 2015-01-15
EP2844344A4 (en) 2016-03-09
JP2018052971A (en) 2018-04-05
DK2844344T3 (en) 2021-04-19
EP2844344A1 (en) 2015-03-11
AU2018204291A1 (en) 2018-07-05
WO2013166459A1 (en) 2013-11-07
AU2020204162B2 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
IN2014DN10291A (en)
MY152710A (en) Oral compositions containing extracts of garcinia mangostana l. and related methods
MX339571B (en) Non-alchohol bioactive essential oil mouth rinses.
CO6460709A2 (en) BORINIC COMPOSITIONS
GB2478478A (en) Composition and method for reducing demineralization of teeth
MX2015007879A (en) Oral care composition.
EP2462914A4 (en) Preparation for oral cavity
CO6571912A2 (en) Oral care product for sensitive enamel care
PL2281528T3 (en) System for laser treatment of dental caries
EA200801824A1 (en) MEDICAL-PREVENTIVE COMPOSITION FOR CARE OF ORAL CAVITY
WO2010121213A3 (en) Antibacterial compositions
MX2018000476A (en) Magnolia bark extract as a hydrophobic ligand for preferential removal of gram negative bacteria from the oral cavity.
UY33309A (en) COMPOSITIONS FOR DENTAL TREATMENT THAT INCLUDE LIPOTEICOIC ACIDS OR PARTS OF THE SAME AS MONKEY OR POLYGLYCERPHOSPHATES
NZ725310A (en) Treating inflammatory conditions and improving oral hygiene using metal modulators with methylsulfonylmethane as transport enhancer
MX2011008898A (en) Desensitizing dentifrice exhibiting dental tissue antibacterial agent uptake.
MX2011006090A (en) Novel use.
MX2011009136A (en) Oral care compositions comprising tetrapotassium pyrophosphate.
UA44673U (en) Method for treating inflammations of periodontium and oral mucosa
EP3721863A3 (en) Protection of materials by sphingosine based compounds
EA200701932A1 (en) TABLET FOR PREVENTION AND TREATMENT OF TEETH DISEASES AND PERIODONTAL
GB2610009B (en) Stable compositions for the treatment of dental caries
MX2012006217A (en) Novel peroxide derivatives, their process of preparation and their use in human medicine and in cosmetics for the treatment or prevention of acne.
UA57223U (en) Method for treating chronic or exacerbated generalized periodontitis
MX2021007647A (en) Oral care compositions.
MX2019015934A (en) Composition comprising an antiseptic, a volatile sulfur compound neutralizer, and an anticariogenic agent.